FindTrial
Sign In

Establishment and Application of an Intelligent Molecular Blood Typing Platform Based on Asymmetric Real-time PCR and Multiplex Melting Curve Analysis

Establishment and Application of an Intelligent Molecular Blood Typing Platform Based on Asymmetric Real-time PCR and Multiplex Melting Curve Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100184
Enrollment
Unknown
Registered
2025-04-03
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical transfusion

Interventions

Gold Standard:Using the sequencing results of the samples as the gold standard.
Index test:Asymmetric Real-time PCR and Multiplex Melting Curve Analysis

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals requiring blood group testing, and individuals who are known to have rare blood types . 2. Willingness to participate in this project.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe underlying medical conditions. 2. Those unable to communicate effectively with the research team.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Agreement;—

Countries

China

Contacts

Public ContactYing Yan

Beijing Hospital

yyan511@nccl.org.cn+86 10 85133609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026